HTF Market
Intelligence released a new research report of 25 pages on title 'Xenon
Pharmaceuticals Inc (XENE) - Financial and Strategic SWOT Analysis Review' with detailed analysis, forecast and
strategies.
Summary
Xenon Pharmaceuticals Inc (Xenon), formerly Xenon
Genetics Inc is a drug development company that discovers and develops of
therapeutics for orphan indications. The company's pipeline products comprise
Glybera, XEN801, sodium channel inhibitor and TV-45070. It discovers various
validated drug targets through the study of rare human diseases with extreme
traits, including channelopathies, diseases caused by mutations in ion
channels. The company’s target treatment areas comprise lipoprotein lipase
deficiency, cardiovascular diseases, dermatology, pain and dravet syndrome. It
operates through partnerships with other drug developers. Xenon is headquartered
in Burnaby, British Columbia, Canada.
Xenon Pharmaceuticals Inc Key Recent Developments
May 09,2017: Xenon Pharmaceuticals Reports First Quarter
2017 Financial Results and Provides Corporate Update
Mar 08,2017: Xenon Pharmaceuticals Reports 2016 Financial
Results and Provides Corporate Update
Jan 08,2017: Xenon Pharmaceuticals Outlines Key
Milestones for 2017
Nov 03,2016: Xenon Pharmaceuticals Reports Third Quarter
2016 Financial Results and Provides Corporate Update
Sep 27,2016: Xenon Pharmaceuticals Appoints Dawn Svoronos
to Its Board of Directors
This comprehensive SWOT profile of Xenon Pharmaceuticals
Inc provides you an in-depth strategic analysis of the company’s businesses and
operations. The profile has been compiled by GlobalData to bring to you a clear
and an unbiased view of the company’s key strengths and weaknesses and the
potential opportunities and threats. The profile helps you formulate strategies
that augment your business by enabling you to understand your partners,
customers and competitors better.
This company report forms part of GlobalData’s ‘Profile
on Demand’ service, covering over 50,000 of the world’s leading companies. Once
purchased, GlobalData’s highly qualified team of company analysts will
comprehensively research and author a full financial and strategic analysis of
Xenon Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this
direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the
company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the
company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s
strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated
with the company.
- Major products and services – A list of major products,
services and brands of the company.
- Key competitors – A list of key competitors to the
company.
- Key employees – A list of the key executives of the
company.
- Executive biographies – A brief summary of the
executives’ employment history.
- Key operational heads – A list of personnel heading key
departments/functions.
- Important locations and subsidiaries – A list and
contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key
manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The
latest financial ratios derived from the annual financial statements published
by the company with 5 years history.
- Interim ratios for the last five interim periods – The
latest financial ratios derived from the quarterly/semi-annual financial
statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is
unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its
operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure,
operations, major products and services, prospects, locations and subsidiaries,
key executives and their biographies and key competitors.
Understand and respond to your competitors’ business
structure and strategies, and capitalize on their weaknesses. Stay up to date
on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas
of development or decline are analyzed and presented in the profile
objectively. Recent developments in the company covered in the profile help you
track important events.
Equip yourself with information that enables you to
sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit
are sized up and its growth potential assessed in the profile. Competitive
and/or technological threats are highlighted.
Scout for potential investments and acquisition targets,
with detailed insight into the companies’ strategic, financial and operational
performance.
- Financial ratio presented for major public companies in
the profile include the revenue trends, profitability, growth, margins and
returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or
business research.
- Key elements such as SWOT analysis, corporate strategy
and financial ratios and charts are incorporated in the profile to assist your
academic or business research needs.
Make an enquiry
before buying this Report @ https://www.htfmarketreport.com/enquiry-before-buy/407841-xenon-pharmaceuticals-inc-4
Table of Contents
Section 1 - About
the Company
Xenon
Pharmaceuticals Inc - Key Information
Xenon
Pharmaceuticals Inc - Overview
Xenon
Pharmaceuticals Inc - Key Employees
Xenon
Pharmaceuticals Inc - Key Employee Biographies
Xenon
Pharmaceuticals Inc - Key Operational Heads
Xenon
Pharmaceuticals Inc - Major Products and Services
Xenon
Pharmaceuticals Inc - History
Xenon
Pharmaceuticals Inc - Company Statement
Xenon
Pharmaceuticals Inc - Locations And Subsidiaries
Xenon
Pharmaceuticals Inc - Key Manufacturing facilities
Head Office
Other Locations
& Subsidiaries
Section 2 -
Company Analysis
Xenon
Pharmaceuticals Inc - Business Description
Xenon
Pharmaceuticals Inc - Corporate Strategy
Xenon
Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis -
Overview
Xenon
Pharmaceuticals Inc - Strengths
Xenon
Pharmaceuticals Inc - Weaknesses
Xenon
Pharmaceuticals Inc - Opportunities
Xenon
Pharmaceuticals Inc - Threats
Xenon
Pharmaceuticals Inc - Key Competitors
Section 3 -
Company Financial Performance Charts
Xenon
Pharmaceuticals Inc - Financial Ratios
Financial Ratios -
Capital Market Ratios
Financial Ratios -
Annual Ratios
Financial Ratios -
Interim Ratios
Financial Ratios -
Ratio Charts
Section 4 -
Appendix
Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Note*: Some
sections may be missing if data is unavailable for the company List of Tables
Xenon
Pharmaceuticals Inc, Key Information
Xenon
Pharmaceuticals Inc, Key Ratios
Xenon Pharmaceuticals
Inc, Share Data
Xenon
Pharmaceuticals Inc, Major Products and Services
Xenon
Pharmaceuticals Inc, History
Xenon
Pharmaceuticals Inc, Key Employees
Xenon
Pharmaceuticals Inc, Key Employee Biographies
Xenon
Pharmaceuticals Inc, Key Operational Heads
Xenon
Pharmaceuticals Inc, Other Locations
Xenon
Pharmaceuticals Inc, Subsidiaries
Xenon
Pharmaceuticals Inc, Key Manufacturing facilities
Xenon
Pharmaceuticals Inc, Key Competitors
Xenon
Pharmaceuticals Inc, SWOT Analysis
Xenon
Pharmaceuticals Inc, Ratios based on current share price
Xenon
Pharmaceuticals Inc, Annual Ratios
Xenon
Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market
Ratios
Equity Ratios
Profitability
Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Xenon
Pharmaceuticals Inc, Performance Chart
Xenon
Pharmaceuticals Inc, Ratio Charts
Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=407841
Contact Us:
CRAIG FRANCIS (PR
& Marketing Manager)
sales@htfmarketreport.com
Ph:
+1 (206) 317 1218
No comments:
Post a Comment